peptides evidence FAQ

Reduce AHK-Cu dose or eliminate peptides that amplify pro-oxidant signaling. Copper at excessive concentrations can shift from antioxidant (SOD mimetic activity) to pro-oxidant (Fenton reaction hydroxyl radical generation). If you're stacking AHK-Cu with compounds that already elevate reactive oxygen species as part of their mechanism. Such as certain melanogenesis-inducing peptides. The combined oxidative load may exceed cellular antioxidant capacity. Symptoms like increased fatigue, delayed recovery, or skin irritation warrant dose reduction or temporary discontinuation to allow redox balance to normalise.

Map each peptide's primary mechanism and ask whether AHK-Cu's copper delivery and collagen synthesis pathway duplicates any existing function. If your current stack includes GHK-Cu or another copper peptide, adding AHK-Cu creates direct redundancy and splits available copper ions without additional benefit. If your stack focuses on growth hormone (ipamorelin), mitochondrial function (MOTS-c), or metabolic health (semaglutide), AHK-Cu addresses a distinct pathway (extracellular matrix remodeling) and adds value rather than overlap.

Administer them separately with no timing restriction. GLP-1 receptor agonists (semaglutide, tirzepatide) work through incretin pathways that regulate insulin secretion and appetite, which don't intersect with copper peptide collagen synthesis. GLP-1 agonists require specific dosing schedules (weekly subcutaneous for semaglutide), while AHK-Cu can be dosed daily or every other day without regard to fasting or meal timing. The only practical consideration is injection site rotation to prevent localised tissue irritation from frequent subcutaneous administration in the same area.

Selank has been studied alongside SSRIs without adverse pharmacokinetic interactions. Its GABAergic modulation is mechanistically distinct from serotonin reuptake inhibition. Combining Selank with benzodiazepines may enhance sedation due to overlapping GABAergic pathways; start at half-dose and assess tolerance. Dihexa, a cognitive-enhancing peptide, should not be combined with benzodiazepines. Its effect on acetylcholine pathways conflicts with GABAergic sedation.

Increase administration frequency to twice daily (morning and evening) rather than once daily. The half-life of intranasal Selank is approximately 5–6 hours, meaning single-dose protocols may not maintain therapeutic plasma levels. Verify you're using the correct concentration: 0.15% intranasal solution is the standard dosing from Russian trials. If using a lyophilised powder you reconstituted yourself, recalculate your dilution. Most home errors occur at the mixing stage.

Switch to subcutaneous administration at 0.5–1mg per injection. Bioavailability drops slightly compared to intranasal, but the irritation resolves. Use bacteriostatic water for reconstitution, not sterile water, to prevent bacterial growth during the 28-day use window. Rotate injection sites (abdomen, lateral thigh) to avoid local tissue inflammation.

Stop the peptide and consult your prescribing physician immediately. Weight loss without ovulatory restoration suggests the therapy is producing a caloric deficit without correcting the underlying LH-driven hyperandrogenism. Add metformin 1500–2000mg daily or inositol supplementation to address the androgen synthesis pathway directly. Recheck total testosterone, free androgen index, and LH:FSH ratio at 12 weeks.

Most insurers deny coverage for GLP-1 therapy in PCOS because the FDA indication is type 2 diabetes and obesity. PCOS alone does not meet criteria. Appeal using metabolic syndrome diagnosis codes if you meet three of five criteria: waist circumference >35 inches, triglycerides ≥150 mg/dL, HDL <50 mg/dL, blood pressure ≥130/85, fasting glucose ≥100 mg/dL. Compounded semaglutide from Real Peptides costs $200–$350 per month without insurance.

Reduce to the previous tolerated dose and extend the titration interval from 4 weeks to 6 weeks per step. PCOS patients with delayed gastric emptying at baseline experience more pronounced GI side effects because GLP-1 agonists further slow motility. Eat smaller, lower-fat meals and avoid lying down within two hours of eating. If nausea persists beyond 8 weeks at a given dose, that dose exceeds your tolerance.